The Token Economy: Why Your AI Bill Doesn't Scale the Way You Think It Does

AI inference doesn't have a fixed cost — and that's the problem. Unlike traditional software, where pricing is predictable per seat or per license, large language models are billed on tokens: a unit of cost that fluctuates with prompt length, model choice, context size, and how many times an agent calls the model in a loop. This talk unpacks "token maxxing" — the pattern where token consumption silently expands to exceed whatever budget was allocated, often driven by context window creep and increasingly autonomous, multi-step agentic workflows. We'll break down how tokens are priced, why open-source and open-weight models change the cost equation, and share concrete, benchmarked strategies — prompt caching, model routing, batching, and agent step budgets — that organizations are using to cut effective spend by 50–95% without sacrificing output quality. Attendees will leave with a practical framework for treating token spend as a governed, measurable resource rather than a surprise line item on next month's invoice.

Gender-Inclusive Patient Recruitment: Enhancing Fairness in Clinical Trials

Gender bias in clinical trials has long been a barrier to developing effective treatments that work for everyone. This session focuses on the critical need to eliminate gender bias in patient recruitment to ensure that clinical trials are inclusive and representative of the entire population.

We'll explore the ways in which gender bias can unintentionally influence trial design, patient selection, and data interpretation, leading to skewed results that fail to account for gender differences in treatment responses. We'll also discuss strategies for identifying and addressing these biases at every stage of the recruitment process, from protocol design to outreach and enrollment.

Participants will learn about innovative approaches and best practices for recruiting a diverse patient population that accurately reflects both male and female experiences. By removing gender bias, we can improve the validity and applicability of clinical trial outcomes, ultimately leading to more equitable healthcare solutions.

Building master data pipelines for commercial Life sciences

n today's fast-evolving life sciences industry, the ability to harness and manage data effectively is critical to staying competitive. This session will dive into the intricacies of building master data pipelines that are tailored for commercial life sciences. We'll explore how to design and implement data infrastructures that centralize and standardize critical information from various sources, including clinical trials, patient records, sales data, and market research.

We'll discuss the importance of data consistency, accuracy, and accessibility in driving business decisions, supporting product development, and ensuring regulatory compliance. Attendees will learn about the key components of master data pipelines— from data extraction, transformation, and loading (ETL) processes to implementing rigorous quality checks and ongoing monitoring.

By the end of this session, you'll have a clear understanding of how effective data pipelines can streamline operations, enhance decision-making, and accelerate the time-to-market for new therapies and products. Join us to discover best practices and innovative approaches to mastering data management in the life sciences sector.

Responsibly Advancing AI in Clinical Trials

As artificial intelligence (AI) rapidly transforms the landscape of clinical trials, the need for responsible implementation has never been more critical. This session will explore how AI can be harnessed to enhance clinical trial design, patient recruitment, data analysis, and outcome prediction, while ensuring ethical considerations are front and center.

We'll delve into the potential of AI to streamline trial processes, reduce costs, and accelerate the development of new therapies. However, with great power comes great responsibility. We'll discuss the challenges of bias, data privacy, transparency, and regulatory compliance, and how to address them to build trust in AI-driven methodologies.

Join us as we navigate the delicate balance between innovation and ethics, and discover best practices for integrating AI into clinical trials in a way that enhances accuracy, efficiency, and fairness. Whether you're a researcher, clinician, or industry professional, this session will provide valuable insights into the responsible advancement of AI in clinical trials, ensuring that technological progress benefits both science and society.

Scaling Video Production with Gemini and Veo

The traditional video production pipeline is often a bottleneck for marketing teams—fraught with high costs, lengthy ideation phases, and technical complexity. But what happens when you treat AI not just as a tool, but as a full-scale production studio?

In this session, we explore a cutting-edge solution designed to help marketers transition from concept to high-fidelity video in record time. We will dive into the architecture of a platform that generates everything from micro-ads to comprehensive training modules, leveraging the combined power of Gemini for orchestration and Veo for cinematic video generation.

We will discuss the real-world hurdles of AI video production, including:

Maintaining brand consistency across generative frames.

The "Ideation Gap": Moving from a rough brief to a structured storyboard.

Bridging the technical divide between LLM logic and visual output.

Attendees will see how automating the creative workflow can save 25-30% in time and resources, allowing teams to focus on strategy rather than the mechanics of production.

Key Takeaways:
The New Production Stack: Understand how Gemini and Veo integrate to create a seamless "script-to-screen" workflow.

Efficiency Metrics: Learn how to quantify the ROI of AI in creative processes (and where that 30% time saving actually comes from).

Overcoming Creative Friction: Practical strategies for solving common challenges in AI video, such as temporal consistency and prompt engineering for video.

Beyond the Hype: A look at the future of "Agentic Creative Studios" where AI acts as the director, editor, and cinematographer.